Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Opdivo
Opdivo
Bristol-Myers takes a big step in its PD-1 lung cancer race with Merck
Fierce Biotech
Mon, 03/2/15 - 12:38 pm
Merck
Bristol-Myers Squibb
lung cancer
anti-PD-1 immunotherapy
Opdivo
Keytruda
Which Cancer Immunotherapy Will Be the Most Successful?
Motley Fool
Sat, 02/28/15 - 12:50 pm
cancer immunotherapy
Opdivo
Bristol-Myers Squibb
Merck
Keytruda
anti-PD-1 immunotherapy
Gilead's hep C star Harvoni, BMS' cancer med Opdivo lead ranks of 'exciting' launches
Fierce Pharma Marketing
Thu, 02/26/15 - 10:23 am
Gilead Sciences
Harvoni
hepatitis C
Bristol-Myers Squibb
Opdivo
melanoma
lung cancer
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
Merck and Bristol-Myers Rivalry in Cancer Drugs Heats Up, Again
WSJ Pharmalot
Mon, 01/12/15 - 12:52 pm
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Bristol-Myers Checkpoint Inhibitor Prolongs Lung Cancer Patient Survival
TheStreet.com
Mon, 01/12/15 - 08:02 am
Bristol-Myers Squibb
Opdivo
lung cancer
squamous cell non-small cell lung cancer
Who will win the Opdivo-Keytruda coverage clash?
Medical Marketing and Media
Tue, 12/30/14 - 10:29 am
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
The Most Important New Drug Of 2014
Forbes
Tue, 12/30/14 - 10:15 am
Ketruda
Merck
Opdivo
Bristol-Myers Squibb
4 Potential Blockbuster Drugs The FDA Just Approved
Investors.com
Fri, 12/26/14 - 10:11 pm
Bristol-Myers Squibb
Opdivo
Merck
Cubist Pharmaceuticals
Zerbaxa
AstraZeneca
Lynparza
Novo Nordisk
Saxenda
A new era of immuno-oncology has arrived
Fierce Biotech
Fri, 12/26/14 - 10:17 am
immuno-oncology
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Roche
Amgen
AstraZeneca
Early Opdivo OK gives BMS more time to erase Keytruda's lead
Medical Marketing and Media
Wed, 12/24/14 - 09:29 am
Opdivo
Bristol-Myers Squibb
Keytruda
melanoma
FDA approves Bristol-Myer's skin cancer drug
Yahoo/Reuters
Mon, 12/22/14 - 04:44 pm
FDA
Opdivo
Bristol-Myers Squibb
melanoma
Opdivo (nivolumab) Demonstrates High Overall Response Rate of 87% for Treatment of Relapsed or Refractory Hodgkin Lymphoma
Yahoo/BusinessWire
Sun, 12/7/14 - 10:11 am
Opdivo
Hodgkin's lymphoma
Bristol-Myers Squibb
Five Prime gets $30M upfront from Bristol-Myers and will study combination cancer treatment
Yahoo/AP
Mon, 11/24/14 - 06:03 pm
Five Prime
Bristol-Myers Squibb
Opdivo
FPA008
melanoma
Bristol-Myers, Pharmacyclics And Janssen Collaborate On OPDIVO And IMBRUVICA
RTT News
Mon, 10/13/14 - 10:14 am
Bristol-Myers Squibb
Pharmacyclics
Janssen
Opdivo
Imbruvica
Novartis works with Bristol-Myers Squibb to test lung cancer drugs
Yahoo/Reuters
Mon, 10/6/14 - 07:29 am
Novartis
Bristol-Myers Squibb
lung cancer
Opdivo
Bristol immune drug shows strong effect in melanoma study
Yahoo/Reuters
Mon, 09/29/14 - 07:46 am
Bristol-Myers Squibb
Opdivo
melanoma
BMS striving to push Opdivo past Keytruda
Medical Marketing and Media
Wed, 09/17/14 - 09:52 am
Bristol-Myers Squibb
Merck
Opdivo
Keytruda
anti-PD-1 immunotherapy
Cancer Drug Approval Is A Triumph For Merck. What's Next?
Forbes
Fri, 09/5/14 - 10:04 am
Merck
melanoma
Keytruda
Bristol-Myers Squibb
Opdivo
Bristol to seek melanoma approval for Opdivo ahead of expectations
Yahoo/Reuters
Thu, 07/10/14 - 10:20 am
Bristol-Myers Squibb
melanoma
Opdivo
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20